Expression of Vascular Endothelial Growth Factor-C in the Trabecular Meshwork of Patients with Neovascular Glaucoma and Primary Open-Angle Glaucoma.

VEGF-C VEGFR3 neovascular glaucoma primary open-angle glaucoma trabecular meshwork

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
02 Jul 2021
Historique:
received: 17 05 2021
revised: 23 06 2021
accepted: 30 06 2021
entrez: 19 7 2021
pubmed: 20 7 2021
medline: 20 7 2021
Statut: epublish

Résumé

To investigate the expression of vascular endothelial growth factor (VEGF)-C and vascular endothelial growth factor receptor (VEGFR)3 in the trabecular meshwork (TM) of patients with glaucoma and cultured TM cells.

Identifiants

pubmed: 34279462
pii: jcm10132977
doi: 10.3390/jcm10132977
pmc: PMC8267742
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ophthalmology. 1998 Feb;105(2):232-7
pubmed: 9479280
BMC Ophthalmol. 2016 Aug 30;16(1):150
pubmed: 27576739
Nat Med. 2001 Feb;7(2):192-8
pubmed: 11175850
Invest Ophthalmol Vis Sci. 2002 Jan;43(1):170-5
pubmed: 11773028
Angiogenesis. 2011 Sep;14(3):371-80
pubmed: 21698469
J Biol Chem. 2004 Jun 25;279(26):27088-97
pubmed: 15102829
Prog Retin Eye Res. 2017 Mar;57:108-133
pubmed: 28028002
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Cochrane Database Syst Rev. 2020 Feb 6;2:CD007920
pubmed: 32027392
EMBO J. 2001 Feb 15;20(4):672-82
pubmed: 11179212
Int J Oncol. 2008 Mar;32(3):585-92
pubmed: 18292935
Am J Med. 2016 Sep;129(9):1000.e7-1000.e13
pubmed: 27125182
Semin Ophthalmol. 2009 Mar-Apr;24(2):113-21
pubmed: 19373696
Dev Ophthalmol. 2016;55:196-204
pubmed: 26501989
Am J Physiol Cell Physiol. 2018 Jul 1;315(1):C44-C51
pubmed: 29631366
Cancer Res. 2001 Mar 1;61(5):1786-90
pubmed: 11280723
J Clin Invest. 2014 Sep;124(9):3975-86
pubmed: 25061878
Am J Cancer Res. 2015 Jan 15;5(2):616-28
pubmed: 25973301
Cell Rep. 2014 Jan 16;6(1):155-67
pubmed: 24388748
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Rom J Ophthalmol. 2015 Jan-Mar;59(1):24-8
pubmed: 27373111
Lancet. 2004 May 22;363(9422):1711-20
pubmed: 15158634
Mol Vis. 2008 Aug 18;14:1513-6
pubmed: 18728789
Exp Eye Res. 1984 Nov;39(5):605-9
pubmed: 6519197
Cancer Res. 2006 Feb 1;66(3):1446-54
pubmed: 16452200
Curr Ophthalmol Rep. 2015 Jun 1;3(2):67-73
pubmed: 26236568
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6523-30
pubmed: 26447988
Prim Care. 2015 Sep;42(3):437-49
pubmed: 26319348
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4912-22
pubmed: 18614807

Auteurs

Keitaro Hase (K)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Satoru Kase (S)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Atsuhiro Kanda (A)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Yasuhiro Shinmei (Y)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Kousuke Noda (K)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Susumu Ishida (S)

Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Hokkaido, Japan.

Classifications MeSH